Benzinga | Oct 19, 2020 09:36AM EDT

UBS Initiates Coverage On GoodRx Holdings with Buy Rating, Announces Price Target of $64

UBS analyst Eric Sheridan initiates coverage on GoodRx Holdings (NASDAQ:GDRX) with a Buy rating and announces Price Target of $64.